Cargando…
Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing
We develop a population pharmacokinetic model to describe Busulfan pharmacokinetics in paediatric patients and investigate by simulations the impact of various sampling schedules on the calculation of AUC. Seventy-six children had 2 h infusions every 6 h. A two-compartment linear model was found to...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948694/ https://www.ncbi.nlm.nih.gov/pubmed/35336021 http://dx.doi.org/10.3390/pharmaceutics14030647 |
_version_ | 1784674714993557504 |
---|---|
author | Neroutsos, Efthymios Nalda-Molina, Ricardo Paisiou, Anna Zisaki, Kalliopi Goussetis, Evgenios Spyridonidis, Alexandros Kitra, Vasiliki Grafakos, Stelios Valsami, Georgia Dokoumetzidis, Aristides |
author_facet | Neroutsos, Efthymios Nalda-Molina, Ricardo Paisiou, Anna Zisaki, Kalliopi Goussetis, Evgenios Spyridonidis, Alexandros Kitra, Vasiliki Grafakos, Stelios Valsami, Georgia Dokoumetzidis, Aristides |
author_sort | Neroutsos, Efthymios |
collection | PubMed |
description | We develop a population pharmacokinetic model to describe Busulfan pharmacokinetics in paediatric patients and investigate by simulations the impact of various sampling schedules on the calculation of AUC. Seventy-six children had 2 h infusions every 6 h. A two-compartment linear model was found to adequately describe the data. A lag-time was introduced to account for the delay of the administration of the drug through the infusion pump. The mean values of clearance, central volume of distribution, intercompartmental clearance, and peripheral volume of distribution were 10.7 L/h, 39.5 L, 4.68 L/h and 17.5 L, respectively, normalized for a Body Weight (BW) of 70 kg. BW was found to explain a portion of variability with an allometric relationship and fixed exponents of 0.75 on clearance parameters and 1 on volumes. Interindividual variability for clearance and volume of distribution was found to be 28% and 41%, respectively, and interoccasion variability for clearance was found to be 11%. Three sampling schedules were assessed by simulations for bias and imprecision to calculate AUC by a non-compartmental and a model-based method. The latter was found to be superior in all cases, while the non-compartmental was unbiased only in sampling up to 12 h corresponding to a once-daily dosing regimen. |
format | Online Article Text |
id | pubmed-8948694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89486942022-03-26 Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing Neroutsos, Efthymios Nalda-Molina, Ricardo Paisiou, Anna Zisaki, Kalliopi Goussetis, Evgenios Spyridonidis, Alexandros Kitra, Vasiliki Grafakos, Stelios Valsami, Georgia Dokoumetzidis, Aristides Pharmaceutics Article We develop a population pharmacokinetic model to describe Busulfan pharmacokinetics in paediatric patients and investigate by simulations the impact of various sampling schedules on the calculation of AUC. Seventy-six children had 2 h infusions every 6 h. A two-compartment linear model was found to adequately describe the data. A lag-time was introduced to account for the delay of the administration of the drug through the infusion pump. The mean values of clearance, central volume of distribution, intercompartmental clearance, and peripheral volume of distribution were 10.7 L/h, 39.5 L, 4.68 L/h and 17.5 L, respectively, normalized for a Body Weight (BW) of 70 kg. BW was found to explain a portion of variability with an allometric relationship and fixed exponents of 0.75 on clearance parameters and 1 on volumes. Interindividual variability for clearance and volume of distribution was found to be 28% and 41%, respectively, and interoccasion variability for clearance was found to be 11%. Three sampling schedules were assessed by simulations for bias and imprecision to calculate AUC by a non-compartmental and a model-based method. The latter was found to be superior in all cases, while the non-compartmental was unbiased only in sampling up to 12 h corresponding to a once-daily dosing regimen. MDPI 2022-03-15 /pmc/articles/PMC8948694/ /pubmed/35336021 http://dx.doi.org/10.3390/pharmaceutics14030647 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Neroutsos, Efthymios Nalda-Molina, Ricardo Paisiou, Anna Zisaki, Kalliopi Goussetis, Evgenios Spyridonidis, Alexandros Kitra, Vasiliki Grafakos, Stelios Valsami, Georgia Dokoumetzidis, Aristides Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing |
title | Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing |
title_full | Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing |
title_fullStr | Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing |
title_full_unstemmed | Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing |
title_short | Development of a Population Pharmacokinetic Model of Busulfan in Children and Evaluation of Different Sampling Schedules for Precision Dosing |
title_sort | development of a population pharmacokinetic model of busulfan in children and evaluation of different sampling schedules for precision dosing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948694/ https://www.ncbi.nlm.nih.gov/pubmed/35336021 http://dx.doi.org/10.3390/pharmaceutics14030647 |
work_keys_str_mv | AT neroutsosefthymios developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT naldamolinaricardo developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT paisiouanna developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT zisakikalliopi developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT goussetisevgenios developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT spyridonidisalexandros developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT kitravasiliki developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT grafakosstelios developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT valsamigeorgia developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing AT dokoumetzidisaristides developmentofapopulationpharmacokineticmodelofbusulfaninchildrenandevaluationofdifferentsamplingschedulesforprecisiondosing |